{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T11:56:32Z","timestamp":1791114992574,"version":"4.1.0"},"reference-count":23,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2006,1,25]],"date-time":"2006-01-25T00:00:00Z","timestamp":1138147200000},"content-version":"vor","delay-in-days":1516,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of the New York Academy of Sciences"],"published-print":{"date-parts":[[2001,12]]},"abstract":"<jats:p><jats:bold>A<jats:sc>bstract<\/jats:sc>: <\/jats:bold> Although there are approximately 68 flaviviruses recognized, vaccines have been developed to control very few human flavivirus diseases. Licensed live attenuated vaccines have been developed for yellow fever (strain 17D) and Japanese encephalitis (strain SA14\u201014\u20102) viruses, and inactivated vaccines have been developed for Japanese encephalitis and tick\u2010borne encephalitis viruses. The yellow fever live attenuated 17D vaccine is one of the most efficacious and safe vaccines developed to date and has been used to immunize more than 300 million people. A number of experimental vaccines are being developed, most notably for dengue. Candidate tetravalent live attenuated dengue vaccines are undergoing clinical trials. Other vaccines are being developed using reverse genetics, DNA vaccines, and recombinant immunogens. In addition, the yellow fever 17D vaccine has been used as a backbone to generate chimeric viruses containing the premembrane and envelope protein genes from other flaviviruses. The \u201cChimerivax\u201d platform has been used to construct chimeric Japanese encephalitis and dengue viruses that are in different phases of development. Similar strategies are being used by other laboratories.<\/jats:p>","DOI":"10.1111\/j.1749-6632.2001.tb02702.x","type":"journal-article","created":{"date-parts":[[2010,7,20]],"date-time":"2010-07-20T23:11:36Z","timestamp":1279667496000},"page":"262-271","source":"Crossref","is-referenced-by-count":61,"title":["Current Status of Flavivirus Vaccines"],"prefix":"10.1111","volume":"951","author":[{"given":"ALAN D.T.","family":"BARRETT","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2006,1,25]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1997.0056"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1006\/biol.1997.0057"},{"key":"e_1_2_7_4_2","unstructured":"Barrett P.N. F. Dorner & S.A. Plotkin. 1999.InVaccines 3rd edit. S.A. Plotkin & W.A. Orenstein Eds.: 767\u2010780. W. B. Saunders. Philadelphia PA."},{"key":"e_1_2_7_5_2","unstructured":"Tsai T.F. G.\u2010J.J. Chang & Y.X. Yu. 1999.InVaccines 3rd edit. S.A. Plotkin & W.A. Orenstein Eds.: 672\u2010710. W. B. Saunders. Philadelphia PA."},{"key":"e_1_2_7_6_2","unstructured":"Monath T.P. 1999.InVaccines 3rd edit. S.A. Plotkin & W.A. Orenstein Eds.: 815\u2010879. W. B. Saunders. Philadelphia PA."},{"key":"e_1_2_7_7_2","doi-asserted-by":"crossref","unstructured":"Dunster L.M.et al.1999. Molecular and biological changes associated with HeLa cell attenuation of wild\u2010type yellow fever virus. Virology 261:309\u2010318.","DOI":"10.1006\/viro.1999.9873"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/171.5.1144"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.2.934-942.2001"},{"key":"e_1_2_7_10_2","unstructured":"Smorodincev A.A. & A.V. Dubov. 1986. Live vaccines against tick\u2010borne encephalitis.InTick\u2010borne Encephalitis and Its Vaccine Prophylaxis. A.A. Smorodincev Ed.: 190\u2010211. Meditsina Leningrad."},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(97)00265-X"},{"key":"e_1_2_7_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00121-3"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00040-2"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8500"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/170.6.1448"},{"key":"e_1_2_7_16_2","first-page":"285","article-title":"Transcription of infectious yellow fever RNA from full\u2010length templates produced by in vitro ligation","volume":"1","author":"Rice C.M.","year":"1989","journal-title":"New Biol."},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0928-0197(98)00035-X"},{"key":"e_1_2_7_18_2","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1128\/JVI.73.4.3095-3101.1999","article-title":"Yellow fever: Japanese encephalitis chimeric viruses: construction and biological properties","volume":"73","author":"Chambers T.J.","year":"1999","journal-title":"J. Virol."},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.12.5477-5485.2000"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.17.8094-8101.2000"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.74.7.3020-3028.2000"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0264-410X(00)00105-5"},{"key":"e_1_2_7_23_2","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1128\/JVI.72.6.4925-4930.1998","article-title":"Induction of protective immunity against Japanese encephalitis in mice by immunization with a plasmid encoding JE virus premembrane and envelope genes","volume":"72","author":"Konishi E.","year":"1998","journal-title":"J. Virol."},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1038\/4031"}],"container-title":["Annals of the New York Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1749-6632.2001.tb02702.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1749-6632.2001.tb02702.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T02:36:18Z","timestamp":1695695778000},"score":1,"resource":{"primary":{"URL":"https:\/\/nyaspubs.onlinelibrary.wiley.com\/doi\/10.1111\/j.1749-6632.2001.tb02702.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2001,12]]}},"alternative-id":["10.1111\/j.1749-6632.2001.tb02702.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1749-6632.2001.tb02702.x","archive":["Portico"],"relation":{},"ISSN":["0077-8923","1749-6632"],"issn-type":[{"value":"0077-8923","type":"print"},{"value":"1749-6632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12]]}}}